Grants>Pathogenesis

Investigators in the Pathogenesis of Infectious Disease

Application deadline: Nov 1, 2013 by 12:00am EDT

Five-year awards provide $500,000 to support accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters. The awards are intended to give recipients the freedom and flexibility to pursue new avenues of inquiry and higher-risk research projects that hold potential for significantly advancing the biochemical, pharmacological, immunological, and molecular biological understanding of how microbes and the human body interact.

Histiocytosis Association 2013 Request for Research Proposals

Conquering the Histiocytic Disorders

The Histiocytosis Association funded more than $300,000 in scientific research in 2012. 

Application for 2013 funding will be accepted online from May 15 to July 31, 2013.

Grant Award Amount: up to $50,000 USD each

Grant Award Date: December 2013

A Rare Community

The Histiocytosis Association is a global nonprofit organization dedicated to addressing the unique needs of
patients and families dealing with the effects of histiocytic disorders while leading the search for a cure. It is the
only organization of its kind, connecting the patient and medical communities to:

• Grow and share knowledge of histiocytic disorders,

• Provide critical emotional and educational support to patients and families, and

• Identify and fund key research initiatives that will lead to a world free of histiocytic disorders.

Funding the Path to a Cure

Proposals for scientific research are being accepted for studies into the causes, mechanisms, and improved
means of treatment for histiocytic disorders. Proposals will be evaluated on the basis of science, feasibility, and
relevance. All proposals should address one or more of the histiocytic disorders; below are areas of particular
interest; however, all relevant areas of interest will be considered.

• Mechanisms of disease pathogenesis

• Biology (maturation, migration and immune function) of dendritic cells, macrophages and/or

• lymphocytes in disease pathogenesis

• Derangements of cytokine production or function

• CNS pathology

• Neuropsychiatric consequences

• Studies of rare forms -- Juvenile xanthogranuloma, Erdheim-Chester disease, Rosai-Dorfman disease

•Studies of histiocytic disorders in adults

• Discovery of new disease markers

• Startup support for pilot studies/clinical trials

Research Grant Applications will be reviewed and evaluated by the Histiocyte Society Scientific Committee for relevance, scientific impact and feasibility. The Histiocytosis Association receives the composite score from this review, and the grant applications are then ranked for funding based upon programmatic needs and the availability of funds in each grant application cycle.

For questions regarding Research grants, please contact grants@histio.org.

Call for Nominations: Carcinogenesis Awards

Carcinogenesis is pleased to invite nominations for the seventh biennial Carcinogenesis Awards. The awards are presented at the biennial meetings of the European Association for Cancer Research. The next presentation will be at the EACR's Biennial Congress: EACR-23, Munich, 5 - 8 July 2014.

SENIOR AWARD

For major contributions to research in the field of carcinogenesis. The winner will be invited to lecture on his or her work at the EACR meeting and be presented with this award and a prize of $2500.

YOUNG INVESTIGATOR AWARD

A prize of $2500 is offered for a recent, significant contribution to carcinogenesis research by an investigator under the age of 40 on 1 July 2013. The winner will be invited to the EACR meeting to give a lecture and be presented with this award.

NOMINATIONS

Nominations are now invited for these awards. Please send the name(s) and address(es) of nominee(s) to the e-mail address below by 1 July 2013, together with reasons for the recommendation, details of relevant publications and a curriculum vitae. Self nominations cannot be accepted. The decision making panel comprises the editors of Carcinogenesis and members of the Editorial Board. A final decision will be made by the end of 2013.

Address for nominations by 1 July 2013 to: carcinogenesis.editorialoffice@oup.com

Maurice Hilleman/Merck Award

ASM’s premier award for major contributions to pathogenesis, vaccine discovery, vaccine development, and/or control of vaccine-preventable diseases. The award is presented in memory of Maurice R. Hilleman, whose work in the development of vaccines has saved the lives of many throughout the world.

Maurice Hilleman/Merck Award  Eligibility:
The nominee must have made outstanding achievements in pathogenesis, vaccine discovery, vaccine development, and/or control of vaccine-preventable diseases.

Award:
A cash prize of $20,000, a commemorative piece, and travel to the ASM General Meeting where the laureate will deliver the Maurice Hilleman/Merck Award lecture.

Deadline: July 1.

Nominations:
Nominations will be considered without updating for three years. Self-nominations and more than one nomination per nominee will not be accepted. Only one nominating form and two supporting forms are accepted per nomination. The two supporters must be persons other than the nominator who are familiar with the nominee's qualifications and accomplishments. Only one of the three individuals involved in the nomination may be employed at the nominee's institution. The nominator and supporters must not share employers. Nominations must consist of the following:

Curriculum vitae, including a list of publications, emailed to awards@asmusa.org
Nominating form
Supporting form

ASM awards are granted at the discretion of the award selection committees and may not be awarded every year.

Sponsor: Merck & Co., Inc.